Su Hongyan, Wang Yan, Liu Shuo, Wang Yue, Liu Qian, Liu Guangxuan, Chen Qin
Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
Acta Pharm Sin B. 2019 Jan;9(1):49-58. doi: 10.1016/j.apsb.2018.10.005. Epub 2018 Oct 24.
Transporter-targeted nanoparticulate drug delivery systems (nano-DDS) have emerged as promising nanoplatforms for efficient drug delivery. Recently, great progress in transporter-targeted strategies has been made, especially with the rapid developments in nanotherapeutics. In this review, we outline the recent advances in transporter-targeted nano-DDS. First, the emerging transporter-targeted nano-DDS developed to facilitate oral drug delivery are reviewed. These include improvements in the oral absorption of protein and peptide drugs, facilitating the intravenous-to-oral switch in cancer chemotherapy. Secondly, the recent advances in transporter-assisted brain-targeting nano-DDS are discussed, focusing on the specific transporter-based targeting strategies. Recent developments in transporter-mediated tumor-targeting drug delivery are also discussed. Finally, the possible transport mechanisms involved in transporter-mediated endocytosis are highlighted, with special attention to the latest findings of the interactions between membrane transporters and nano-DDS.
靶向转运体的纳米颗粒药物递送系统(纳米药物递送系统)已成为高效药物递送的有前景的纳米平台。最近,靶向转运体策略取得了巨大进展,尤其是随着纳米治疗学的快速发展。在本综述中,我们概述了靶向转运体的纳米药物递送系统的最新进展。首先,综述了为促进口服药物递送而开发的新兴靶向转运体纳米药物递送系统。这些包括改善蛋白质和肽类药物的口服吸收,促进癌症化疗中静脉给药向口服给药的转变。其次,讨论了转运体辅助脑靶向纳米药物递送系统的最新进展,重点是基于特定转运体的靶向策略。还讨论了转运体介导的肿瘤靶向药物递送的最新进展。最后,强调了转运体介导的内吞作用中可能涉及的转运机制,特别关注膜转运体与纳米药物递送系统之间相互作用的最新发现。
Acta Pharm Sin B. 2019-1
J Control Release. 2017-8-26
Asian J Pharm Sci. 2020-3
Asian J Pharm Sci. 2020-3
Biomaterials. 2021-4
Asian J Pharm Sci. 2020-3
Biomaterials. 2013-3-5
Mol Ther Nucleic Acids. 2024-9-16
Int J Nanomedicine. 2024
Drug Deliv Transl Res. 2025-2
Recent Pat Nanotechnol. 2025
Int J Nanomedicine. 2024
Acta Pharm Sin B. 2023-6
Acta Pharm Sin B. 2023-6
Acta Pharm Sin B. 2018-1
Acta Pharm Sin B. 2018-1
Eur J Pharm Biopharm. 2018-5-24
Acta Pharm Sin B. 2018-3
Curr Clin Pharmacol. 2018